Physician profile
Van T Tran
NPI 1013963255
$1,823.73
in general payments reported to CMS, 2019-2025
33 companies · $27.77 in 2025
The $27.77 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $258 · 2020: $1,052 · 2021: $369 · 2022: $12.10 · 2023: $67.11 · 2024: $37.04 · 2025: $27.77.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $132.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $131.92 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medicure Pharma INC. | $283.66 | 2020 | |
| Novo Nordisk INC | $172.01 | 2019-2021 | |
| Amarin Pharma, INC. | $154.90 | 2019-2021 | |
| Abbvie INC. | $132.09 | 2020-2022 | |
| Amgen INC. | $103.11 | 2019-2020 | |
| Pfizer INC. | $92.46 | 2019-2021 | |
| Astrazeneca Pharmaceuticals LP | $85.25 | 2020-2021 | |
| Otsuka America Pharmaceutical, INC. | $79.98 | 2023-2025 | Rexulti, Abilify Asimtufii, Abilify Maintena |
| Boehringer Ingelheim Pharmaceuticals, INC. | $70.43 | 2019-2020 | |
| Upsher-Smith Laboratories LLC | $62.55 | 2020-2021 | |
| Abbott Laboratories | $51.12 | 2019-2023 | Freestyle Libre 3 |
| Lilly USA, LLC | $47.58 | 2020 | |
| Collegium Pharmaceutical, INC. | $46.73 | 2020-2021 | |
| Eisai INC. | $42.33 | 2020 | |
| Merck Sharp & Dohme LLC | $40.23 | 2020 |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $35.16 | 2020 | |
| Teva Pharmaceuticals USA, INC. | $32.64 | 2020-2021 | |
| Esperion Therapeutics, INC. | $31.42 | 2020-2021 | |
| Biohaven Pharmaceuticals, INC. | $28.49 | 2020-2021 | |
| Medtronic Minimed, INC. | $24.00 | 2020 | |
| Ani Pharmaceuticals, INC. | $23.61 | 2024 | Yutiq |
| Takeda Pharmaceuticals U.S.A., INC. | $22.90 | 2020 | |
| Mylan Pharmaceuticals INC. | $20.91 | 2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $16.81 | 2020 | |
| Vanda Pharmaceuticals INC. | $16.37 | 2020 | |
| Agile Therapeutics, INC. | $15.30 | 2021 | |
| Avion Pharmaceuticals | $14.68 | 2021 | |
| Ironwood Pharmaceuticals, INC | $14.33 | 2020 | |
| Sun Pharmaceutical Industries INC. | $13.59 | 2023 | Cequa |
| Kowa Pharmaceuticals America, INC. | $12.50 | 2019 | |
| Supernus Pharmaceuticals, INC. | $12.47 | 2019 | |
| Shire North American Group INC | $12.32 | 2019 | |
| Zyla Life Sciences, INC. | $11.80 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Van Tran listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.